Stocks in the health care sector are vulnerable to declines following the 2016 presidential election, according to S&P analyst Scott Kessler. Kessler addressed the topic in a panel hosted by TheStreet. "[Last year] Clinton tweeted about the notion of drug pricing and she's continued to communicate about how something should be done." On September 21, 2015, Clinton linked to a NY Times article on Twitter about pharma executive Martin Shkreli's decision to increase the price of a life-saving drug from $13.50 a tablet to $750. Clinton called the increase "outrageous."